World Leader in Genetic Risk Assessment

Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology.

Listed on the ASX(GTG) in 2000.

Listed on the NASDAQ (GENE) in 2005.

International R&D and commercialisation partner to:

universities
research organisations
progressive medical product distribution companies

Who we are

We are a molecular diagnostics company that offers predictive testing and assessment tools to empower physicians to proactively manage patient health

We empower individuals to manage and reduce their risk of contracting cancer and other chronic diseases
We strive to maintain our standing as a global leader in genomics

Our values

Dynamic

Proactive, striving, responsive and motivated

Professional

Punctual, trustworthy, accountable and respectful

Collaborative

Informative, receptive, transparent, cooperative

Passionate

Dedicated, enthusiastic, energetic, inspiring